Versartis Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.05 |
Market Cap |
$54.36 M |
Shares Outstanding |
36.24 M |
Public Float |
27.58 M |
Address |
1020 Marsh Roade Menlo Park California 94025 United States |
Employees | - |
Website | http://www.versartis.com |
Updated | 09/14/2018 |
Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. |